PCSK9 Inhibitors: Revolutionizing Cholesterol Management and Market Dynamics PCSK9 inhibitors have emerged as one of the most transformative innovations in cardiovascular disease management, particularly for patients with high cholesterol who are unresponsive to statins or other traditional therapies. These drugs function by blocking the PCSK9 protein, which leads to increased recycling of LDL...